Categories
Breast Cancer

CytoDyn reveals results for cancer and NASH patients receiving its flagship drug leronlimab [Video]

CytoDyn Inc CEO Nader Pourhassan joined Proactive to discuss results from its current cancer study and from its NASH study on leronlimab, a monoclonal antibody investigational drug the company is developing, suggesting a sharp rise in survival rates.

The study uses varying doses of the drug to treat 28 patients with CCR5+ Metastatic Triple-Negative Breast Cancer, who had failed at least two lines of previous therapy.

Pourhassan also discussed preliminary results from the first five patients treated with leronlimab in its open label Phase 2 trial for Non-alcoholic steatohepatitis , an advanced form of non-alcoholic fatty liver disease.

Watch/Read More
Categories
Breast Cancer

Fairfield's police chief announces retirement, citing breast cancer diagnosis [Video]

Fairfield's police chief announced Tuesday that she plans to retire by the end of the year, citing her being diagnosed with cancer. Deanna Cantrell became Fairfield's first-ever female chief less than two years ago, and she has been in law enforcement for more than 28 years. "This recent diagnosis has really accelerated my plans for the future," Cantrell said. "I have absolutely loved being your police chief in Fairfield and serving you."